[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f3nA8ouSjEYip7benhUJh73kPO9orFQ8PpRpzK9jcCII":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":31,"phaseBuckets":47,"rows":54},"Gadjah Mada University",[4],57,false,20,1,20434,4,44,[14,17,19,21,23,25,27,29],{"name":15,"count":16},"Pregnancy Related",2,{"name":18,"count":16},"Neutropenic Fever",{"name":20,"count":16},"Acute Lymphoblastic Leukemia",{"name":22,"count":16},"Blood Pressure",{"name":24,"count":16},"HIV\u002FAIDS",{"name":26,"count":16},"Smoking Cessation",{"name":28,"count":16},"Depression in Adults",{"name":30,"count":9},"PCOS (Polycystic Ovary Syndrome)",[32,37,42],{"nctId":33,"briefTitle":34,"date":35,"intervention":36},"NCT07183215","Efficacy Test of Curcuminoid Standardized Turmeric Capsules to Improving Inflammatory Biomarkers in Osteoarthritis Genu","2025-09-30","Curcuminoid Standardized Turmeric",{"nctId":38,"briefTitle":39,"date":40,"intervention":41},"NCT07016165","Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies","2025-11-30","Ceftazidime",{"nctId":43,"briefTitle":44,"date":45,"intervention":46},"NCT07320534","Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase","2026-07-31","Levofloxacin",[48,49,50,51,52,53],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[55,81,99,121,143,170,188,215,241,269,287,313,340,367,396,420],{"intervention":41,"totalTrials":9,"cells":56},{"EARLY_PHASE1":57,"PHASE1":60,"PHASE2":62,"PHASE3":64,"PHASE4":66,"NA":79},{"trials":58,"activeCount":59},[],0,{"trials":61,"activeCount":59},[],{"trials":63,"activeCount":59},[],{"trials":65,"activeCount":59},[],{"trials":67,"activeCount":9,"soonestReadout":40},[68],{"nctId":38,"briefTitle":39,"status":69,"phases":70,"primaryCompletion":40,"completion":71,"start":72,"enrollment":73,"conditions":74,"interventions":77},"RECRUITING",[52],"2025-12-31","2025-06-01",120,[18,20,75,76],"Acute Myeloblastic Leukemia","Non Hodgkin Lymphoma",[41,78],"Ciprofloxacin",{"trials":80,"activeCount":59},[],{"intervention":78,"totalTrials":9,"cells":82},{"EARLY_PHASE1":83,"PHASE1":85,"PHASE2":87,"PHASE3":89,"PHASE4":91,"NA":97},{"trials":84,"activeCount":59},[],{"trials":86,"activeCount":59},[],{"trials":88,"activeCount":59},[],{"trials":90,"activeCount":59},[],{"trials":92,"activeCount":9,"soonestReadout":40},[93],{"nctId":38,"briefTitle":39,"status":69,"phases":94,"primaryCompletion":40,"completion":71,"start":72,"enrollment":73,"conditions":95,"interventions":96},[52],[18,20,75,76],[41,78],{"trials":98,"activeCount":59},[],{"intervention":46,"totalTrials":9,"cells":100},{"EARLY_PHASE1":101,"PHASE1":103,"PHASE2":105,"PHASE3":107,"PHASE4":109,"NA":119},{"trials":102,"activeCount":59},[],{"trials":104,"activeCount":59},[],{"trials":106,"activeCount":59},[],{"trials":108,"activeCount":59},[],{"trials":110,"activeCount":9,"soonestReadout":45},[111],{"nctId":43,"briefTitle":44,"status":112,"phases":113,"primaryCompletion":45,"completion":114,"start":115,"enrollment":116,"conditions":117,"interventions":118},"NOT_YET_RECRUITING",[52],"2026-08-31","2026-01-01",124,[18,20],[46],{"trials":120,"activeCount":59},[],{"intervention":36,"totalTrials":9,"cells":122},{"EARLY_PHASE1":123,"PHASE1":125,"PHASE2":127,"PHASE3":129,"PHASE4":139,"NA":141},{"trials":124,"activeCount":59},[],{"trials":126,"activeCount":59},[],{"trials":128,"activeCount":59},[],{"trials":130,"activeCount":9,"soonestReadout":35},[131],{"nctId":33,"briefTitle":34,"status":132,"phases":133,"primaryCompletion":35,"completion":134,"start":72,"enrollment":135,"conditions":136,"interventions":138},"ENROLLING_BY_INVITATION",[50,51],"2025-10-30",72,[137],"Osteoarthritis",[36],{"trials":140,"activeCount":59},[],{"trials":142,"activeCount":59},[],{"intervention":144,"totalTrials":9,"cells":145},"ASIMOMMY®",{"EARLY_PHASE1":146,"PHASE1":148,"PHASE2":150,"PHASE3":164,"PHASE4":166,"NA":168},{"trials":147,"activeCount":59},[],{"trials":149,"activeCount":59},[],{"trials":151,"activeCount":59},[152],{"nctId":153,"briefTitle":154,"status":155,"phases":156,"primaryCompletion":157,"completion":157,"start":158,"enrollment":159,"conditions":160,"interventions":162},"NCT05596006","Efficacy of ASIMOMMY® Compared to Domperidone and Placebo in Increasing Breastfeeding: Randomized Single-Blind Controlled Trial in Indonesia","COMPLETED",[50],"2023-03-24","2022-12-31",45,[161],"Breastfeeding Mothers",[144,163],"Domperidon",{"trials":165,"activeCount":59},[],{"trials":167,"activeCount":59},[],{"trials":169,"activeCount":59},[],{"intervention":163,"totalTrials":9,"cells":171},{"EARLY_PHASE1":172,"PHASE1":174,"PHASE2":176,"PHASE3":182,"PHASE4":184,"NA":186},{"trials":173,"activeCount":59},[],{"trials":175,"activeCount":59},[],{"trials":177,"activeCount":59},[178],{"nctId":153,"briefTitle":154,"status":155,"phases":179,"primaryCompletion":157,"completion":157,"start":158,"enrollment":159,"conditions":180,"interventions":181},[50],[161],[144,163],{"trials":183,"activeCount":59},[],{"trials":185,"activeCount":59},[],{"trials":187,"activeCount":59},[],{"intervention":189,"totalTrials":9,"cells":190},"Riboflavin-Moxifloxacin Amniotic Membrane",{"EARLY_PHASE1":191,"PHASE1":193,"PHASE2":195,"PHASE3":209,"PHASE4":211,"NA":213},{"trials":192,"activeCount":59},[],{"trials":194,"activeCount":59},[],{"trials":196,"activeCount":59},[197],{"nctId":198,"briefTitle":199,"status":155,"phases":200,"primaryCompletion":201,"completion":202,"start":203,"enrollment":204,"conditions":205,"interventions":208},"NCT07559149","Effectiveness of Riboflavin-Moxifloxacin Amniotic Membrane as an Adjuvant for PACK-CXL in Moderate to Severe Infectious Keratitis",[50],"2025-02-13","2025-08-14","2024-07-07",32,[206,207],"Infected Corneal Ulcers","CXL",[189],{"trials":210,"activeCount":59},[],{"trials":212,"activeCount":59},[],{"trials":214,"activeCount":59},[],{"intervention":216,"totalTrials":9,"cells":217},"virgin coconut oil",{"EARLY_PHASE1":218,"PHASE1":220,"PHASE2":222,"PHASE3":235,"PHASE4":237,"NA":239},{"trials":219,"activeCount":59},[],{"trials":221,"activeCount":59},[],{"trials":223,"activeCount":59},[224],{"nctId":225,"briefTitle":226,"status":227,"phases":228,"primaryCompletion":229,"completion":229,"start":230,"enrollment":231,"conditions":232,"interventions":234},"NCT04594330","Virgin Coconut Oil (VCO) as a Potential Adjuvant Therapy in COVID-19 Patients","UNKNOWN",[50],"2020-12-31","2020-06-01",60,[233],"Coronavirus Infections",[216],{"trials":236,"activeCount":59},[],{"trials":238,"activeCount":59},[],{"trials":240,"activeCount":59},[],{"intervention":242,"totalTrials":9,"cells":243},"extract Binahong",{"EARLY_PHASE1":244,"PHASE1":246,"PHASE2":261,"PHASE3":263,"PHASE4":265,"NA":267},{"trials":245,"activeCount":59},[],{"trials":247,"activeCount":59},[248],{"nctId":249,"briefTitle":250,"status":227,"phases":251,"primaryCompletion":252,"completion":253,"start":254,"enrollment":255,"conditions":256,"interventions":259},"NCT05960526","Nasal Irrigation With Combination of 0.9% NaCl and Binahong Extract (Anredera Cordifolia) 2,5% In Allergic Rhinitis",[49],"2024-09-06","2024-12-10","2023-05-06",80,[257,258],"Allergic Rhinitis","Allergic Rhinitis Due to House Dust Mite",[242,260],"Isotonic saline nasal irrigation",{"trials":262,"activeCount":59},[],{"trials":264,"activeCount":59},[],{"trials":266,"activeCount":59},[],{"trials":268,"activeCount":59},[],{"intervention":260,"totalTrials":9,"cells":270},{"EARLY_PHASE1":271,"PHASE1":273,"PHASE2":279,"PHASE3":281,"PHASE4":283,"NA":285},{"trials":272,"activeCount":59},[],{"trials":274,"activeCount":59},[275],{"nctId":249,"briefTitle":250,"status":227,"phases":276,"primaryCompletion":252,"completion":253,"start":254,"enrollment":255,"conditions":277,"interventions":278},[49],[257,258],[242,260],{"trials":280,"activeCount":59},[],{"trials":282,"activeCount":59},[],{"trials":284,"activeCount":59},[],{"trials":286,"activeCount":59},[],{"intervention":288,"totalTrials":9,"cells":289},"Formula milk with triple Bifidobacterium probiotic strain",{"EARLY_PHASE1":290,"PHASE1":292,"PHASE2":305,"PHASE3":307,"PHASE4":309,"NA":311},{"trials":291,"activeCount":59},[],{"trials":293,"activeCount":59},[294],{"nctId":295,"briefTitle":296,"status":227,"phases":297,"primaryCompletion":298,"completion":299,"start":300,"enrollment":301,"conditions":302,"interventions":304},"NCT06044376","Ingestion Effect of Formula Milk With Triple Bifidobacteria Strains on Fecal Quality and Metabolites in Healthy Children",[49],"2023-11-09","2024-03-31","2023-05-02",103,[303],"Children, Only",[288],{"trials":306,"activeCount":59},[],{"trials":308,"activeCount":59},[],{"trials":310,"activeCount":59},[],{"trials":312,"activeCount":59},[],{"intervention":314,"totalTrials":9,"cells":315},"adypose mesenchymal conditioned medium and ligament derived conditioned medium",{"EARLY_PHASE1":316,"PHASE1":330,"PHASE2":332,"PHASE3":334,"PHASE4":336,"NA":338},{"trials":317,"activeCount":59},[318],{"nctId":319,"briefTitle":320,"status":227,"phases":321,"primaryCompletion":322,"completion":322,"start":323,"enrollment":324,"conditions":325,"interventions":329},"NCT04889963","Regeneration of Posterior Cruciate Ligament Injury Using Hypoxic Conditioned Allogenic Adipose Mesenchymal Stem Cell and Condition Medium",[48],"2021-06-30","2021-01-01",16,[326,327,328],"Adypose Mesenchimal Stem Cell","Ligament Rupture","Ligament Derived Conditined Medium",[314],{"trials":331,"activeCount":59},[],{"trials":333,"activeCount":59},[],{"trials":335,"activeCount":59},[],{"trials":337,"activeCount":59},[],{"trials":339,"activeCount":59},[],{"intervention":341,"totalTrials":9,"cells":342},"dihydroartemisinin-piperaquine",{"EARLY_PHASE1":343,"PHASE1":345,"PHASE2":347,"PHASE3":349,"PHASE4":351,"NA":353},{"trials":344,"activeCount":59},[],{"trials":346,"activeCount":59},[],{"trials":348,"activeCount":59},[],{"trials":350,"activeCount":59},[],{"trials":352,"activeCount":59},[],{"trials":354,"activeCount":59},[355],{"nctId":356,"briefTitle":357,"status":155,"phases":358,"primaryCompletion":359,"completion":360,"start":361,"enrollment":362,"conditions":363,"interventions":366},"NCT02001428","Malaria in Early Life Study",[53],"2016-03-31","2017-05-17","2014-07-21",757,[364,365],"Plasmodium Falciparum Malaria","Plasmodium Vivax Malaria",[341],{"intervention":368,"totalTrials":9,"cells":369},"Wolbachia-infected Aedes aegypti mosquitoes",{"EARLY_PHASE1":370,"PHASE1":372,"PHASE2":374,"PHASE3":376,"PHASE4":378,"NA":380},{"trials":371,"activeCount":59},[],{"trials":373,"activeCount":59},[],{"trials":375,"activeCount":59},[],{"trials":377,"activeCount":59},[],{"trials":379,"activeCount":59},[],{"trials":381,"activeCount":59},[382],{"nctId":383,"briefTitle":384,"status":385,"phases":386,"primaryCompletion":387,"completion":388,"start":389,"enrollment":390,"conditions":391,"interventions":395},"NCT03055585","Applying Wolbachia to Eliminate Dengue","TERMINATED",[53],"2020-03-18","2020-04-08","2017-11-08",8173,[392,393,394],"Dengue","Zika Virus Infection","Chikungunya Fever",[368],{"intervention":397,"totalTrials":9,"cells":398},"Prolotherapy",{"EARLY_PHASE1":399,"PHASE1":401,"PHASE2":403,"PHASE3":405,"PHASE4":407,"NA":409},{"trials":400,"activeCount":59},[],{"trials":402,"activeCount":59},[],{"trials":404,"activeCount":59},[],{"trials":406,"activeCount":59},[],{"trials":408,"activeCount":59},[],{"trials":410,"activeCount":59},[411],{"nctId":412,"briefTitle":413,"status":155,"phases":414,"primaryCompletion":415,"completion":415,"start":416,"enrollment":417,"conditions":418,"interventions":419},"NCT07355712","Combined Effect of Prolotherapy and Personalized Physical Activity on Knee Osteoarthritis Progression",[53],"2025-10-01","2024-07-10",74,[397],[397],{"intervention":421,"totalTrials":9,"cells":422},"Analgesics, etoricoxibe",{"EARLY_PHASE1":423,"PHASE1":425,"PHASE2":427,"PHASE3":429,"PHASE4":431,"NA":433},{"trials":424,"activeCount":59},[],{"trials":426,"activeCount":59},[],{"trials":428,"activeCount":59},[],{"trials":430,"activeCount":59},[],{"trials":432,"activeCount":59},[],{"trials":434,"activeCount":59},[435],{"nctId":436,"briefTitle":437,"status":227,"phases":438,"primaryCompletion":439,"completion":439,"start":230,"enrollment":231,"conditions":440,"interventions":443},"NCT04883034","Adductor Canal Block in Outpatient Clinic for Pain Control After Knee Arthroplasty",[53],"2021-06-01",[441,442],"Acute Pain","Total Knee Arthroplasty",[421]]